Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Trillium Therapeutics Inc. T.TR

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  V.SSS| SCTPD| SCTPF

Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immuno regulatory pathways that tumor cells exploit to evade the host immune system.
Price: $20.25 Volume: 725
Change: +$0.04 % Change: +0.20%
Day High/Low: 20.25/19.79 52 Week High/Low: 37.27/7.02
Last Traded: November 26, 2015 10:53 Transaction Volume: 100
Open: 19.79 Previous Close: 20.21
Bid: 20.09 Ask: 20.48
Bid Size: 300 Ask Size: 500
Market Cap: 148.8m Shares Out: 7.3m
PE Ratio: N/A Dividend Yield: N/A


Technology that may save lives: Stem Cell Therapeutics

Stock has been fairly range-bound in terms of price since last May   March 16, 2009
0 stars

Latest Bullboard Posts